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Introduction
Several highly prevalent and debilitating conditions
involve pain in the trigeminal distribution. Although
effective treatments exist, for many patients these treat-
ments are far from optimal. Therefore understanding
the pathophysiology of pain in the craniofacial region is
critical. CGRP plays an essential role in the process of
peripheral and central sensitization in the trigeminovas-
cular system. Release of CGRP contributes to the pro-
cess of neurogenic inflammation generating allodynia
and hyperalgesia, clinical characteristics in neuropathic,
inflammatory and migraine pain.
Objectives
To study the effect of the CGRP receptor antagonist,
MK-8825, on responses to trigeminal nociception and
trigeminal nucleus caudalis (TNC) activation, using a
mouse model of trigeminal nociception.
Methods
C57BL/6 mice received either a subcutaneous injection of
the MK-8825 (70mg/kg) or vehicle alone, followed by an
injection of 0.9% saline solution or complete Freund’s
adjuvant (CFA) in their right masseter muscle, shown
previously to produce nociceptive-specific specific
grooming behaviors. Animals were video recorded for
assessment of nociceptive behaviors for one hour. Mice
were overdosed with isoflurane and perfused transcar-
dially at 2 or 24 hours after the MK-8825 injection. The
brainstem was removed the area of the TNC was pre-
pared and reacted for Fos immunoreactivity to verify
neuronal activation.
Results
Mice that received MK-8825, with CFA injection in the
masseter, spent significantly less time exhibiting nocicep-
tive behaviors compared to those that received vehicle
(P < 0.05). At 2 and 24hrs after CFA injection mice that
received MK-8825 had a significantly lower level of Fos
immunoreactivity in the ipsilateral TNC compared to
those that received CFA and vehicle.
Conclusion
MK-8825 decreases pain behaviors and neuronal activa-
tion in the TNC of mice with inflammatory pain in the
trigeminal mandibular distribution. CGRP likely contri-
butes to the pathophysiological mechanism of this pain
response.
Conflicts
Grant funding from MERCK Sharp & Dohme Corp,
This work has been supported in part by a research
grant from the Investigator Initiated Studies Program of
Merck Sharp & Dohme Corp and 2009 AHS/MRF Tho-
mas E. Heftler Migraine Research Award. We want to
thank Dr. Andrew Charles for helpful discussions.
Conflicts
Dr. Marcela Romero has received grant funding from
Merck Sharp & Dohme Corp to conduct this study.
Dr. Simon Akerman has consulted for Merck Sharp &
Dohme Corp and MAP Pharmaceuticals
Author details
1NYU College of Dentistry, USA. 2University of California, San Francsico, USA.
Published: 21 February 2013
1NYU College of Dentistry, USA
Full list of author information is available at the end of the article
Romero-Reyes and Akerman The Journal of Headache and
Pain 2013, 14(Suppl 1):P93
http://www.thejournalofheadacheandpain.com/content/14/S1/P93
© 2013 Romero-Reyes and Akerman; licensee Springer. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
doi:10.1186/1129-2377-14-S1-P93
Cite this article as: Romero-Reyes and Akerman: The effect of the CGRP
receptor antagonist (MK-8825) on the response to trigeminal
nociception in rodents. The Journal of Headache and Pain 2013 14(Suppl
1):P93.
Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Romero-Reyes and Akerman The Journal of Headache and
Pain 2013, 14(Suppl 1):P93
http://www.thejournalofheadacheandpain.com/content/14/S1/P93
Page 2 of 2
